Hansa Biopharma: increase in number of shares and votes
Lund, Sweden June 28, 2024. Hansa Biopharma AB, (“Hansa Biopharma” or the “Company”) (Nasdaq Stockholm: HNSA) today announced that Hansa’s registered share capital and number of shares and votes have increased through (i) the issue of 2,305,260 new ordinary shares resolved on 12 April 2024 and registered with the Swedish Companies Registration Office during June 2024, whereby the number of votes increased with 2,305,260 and the share capital increased with SEK 2,305,260, and (ii) conversion of all 2,362,445 issued class C shares in Hansa to a total of 2,362,445 ordinary shares, in order to